임신 중 흡연 노출 평가-곽호석
-
Upload
mothersafe -
Category
Documents
-
view
649 -
download
3
Transcript of 임신 중 흡연 노출 평가-곽호석
임신 중 흡연 노출 평가를 위한
바이오 마커 개발
진단검사의학과곽호석
Tobacco smoke
• Tobacco smoke component: > 5,000 chemi-
cals
• Electronic database of smoke components:
>2,000 chemicals
–Mainstream smoke: 542 chemicals
• Human inhalation risk: 98 chemi-
calsA list of smoke components needs to be selected with a suffi-ciently broad chemical, toxicological, and pharmacological pro-file.
List of harzardous tobacco smoke compo-nents
Int. J. Environ. Res. Public Health 2011, 8
Int. J. Environ. Res. Public Health 2011, 8
Hazardous tobacco smoke component
• The list of Hoffmann analytes: biolog-
ically or toxicologically active main-
stream smoke components
– Based on research from the early 1990s
– Only includes carcinogens
The list of Hoffmann analytesGroup Analytes Average Yields
Aromatic Amines
1-Aminonaphthalene (ng/cig) 15.1
2-Aminonaphthalene (ng/cig) 10.3
3-Aminobiphenyl (ng/cig) 3
4-Aminobiphenyl (ng/cig) 1.7
Carbonyls
Methyl ethyl ketone (μg/cig) 62.72
Acetaldehyde (μg/cig) 560.48
Acetone (μg/cig) 264.74
Acrolein (μg/cig) 58.77
Butyraldehyde (μg/cig) 29.58
Crotonaldehyde (μg/cig) 16.18
Formaldehyde (μg/cig) 21.61
Propionaldehyde (μg/cig) 43.92
Phenols
Catechol (μg/cig) 37.9
Hydroquinone (μg/cig) 32.4
m+p-Cresol (μg/cig) 5.84
o-Cresol (μg/cig) 1.89
Phenol (μg/cig) 7.32
Resorcinol (μg/cig) 0.91
Polycyclic Aromatic Hydrocarbon (PAH)
Benzo[a]pyrene (ng/cig) 7
Group Analytes Average Yields
Inorganics
Ammonia (μg/cig) 11.02
Hydrogen Cyanide (μg/cig) 109.2
Nitric Oxide (μg/cig) 223.41
Carbon Monoxide (mg/cig) 11.96
Organics Acrylonitrile (μg/cig) 8.28
Volatile Hydrocarbons
1,3-Butadiene (μg/cig) 29.94
Benzene (μg/cig) 43.39
Isoprene (μg/cig) 297.68
Toluene (μg/cig) 64.91
Styrene (μg/cig) 5.11
Nitrogen Hetero-cyclics
Pyridine (μg/cig) 7.02
Quinoline (μg/cig) 0.23
Nicotine (mg/cig) 0.75 (750ug)
Metals & Metalloids
Arsenic (ng/cig) 10.4
Cadmium (ng/cig) 47.8
Chromium (ng/cig) 73
Lead (ng/cig) 33
Mercury (ng/cig) 3.82
Nickel (ng/cig) 5.12
Selenium (ng/cig) 34.9
Tobacco Specific Nitrosamines (T-
SNAs)
NAB (ng/cig) 16.3 (0.016ug)
NAT (ng/cig) 119 (0.119ug)
NNK (ng/cig) 115.6 (0.116ug)
NNN (ng/cig) 133.1 (0.133ug)
'Tar' Nicotine-free-dry-particu-late-matter (mg/cig) 8.91
Biomarkers of tobacco smoke ex-posure
• Carbon monoxide (CO)• Nicotine metabolite: Cotinine• Polycyclic aromatic hydrocarbon
(PAHs) metabolite: 2-naphthol, 3-hy-droxyfluorenes, 1-hydroxypyrene
• Tobacco specific nitrosamines (TSNAs) metabolite: NNAL
Tobacco-specific nitrosamines(TSNAs)
Processed tobaccos are invariably contaminated with TSNAs.
Formed during processing (drying and fermentation)
Not present in fresh and green tobaccos
Different types of tobacco contain different concentrations of ni-
trosamines
The higher the nitrate content of tobaccos the higher also the nitrosamine con-
tamination
The high-nitrate tobaccos or other dark tobacco types are high in TSNAs
No correlation between the declared tar content of cigarettes and
the TSNA concentration in mainstream tobacco smoke
No evidence that nicotine is nitrosated during the smoking process
Range for tar, nicotine and tobacco specific ni-trosamine (TSNA) in tobacco for commercial ciga-
rettes from several countries
Results of testing for NNK yields from three brands of cigarettes in various countries
We see these results as a compelling and urgent argument for government regulation of carcinogen concentrations in ciga-rettes.
Tobacco Control 2000;9:351–354
Nicotine yield range
0.85 mg/cig to 1.3 mg/cig 0.68 mg/cig to 1.25 mg/cig
Chemical structure of TSNAs
Nitrosation
Nitrosamine structure
Formation of tobacco-specific nitrosamines in tobacco
Potential third-hand smoke
PNAS ∣ April 13, 2010 ∣ vol. 107 ∣ no. 15
The metabolic activation and inactivation of NNK
* 11β-HSD: 11β-hydroxysteroid dehydrogenase
Steroid hormonesDrug: diureticsDrug: block 11β-HSDDrugDrug: flavonoidFlavanone
Similar structure: hormones
Chemical structure of NNAL
11β-HSD
Metabolism of NNK and NNAL and formation of adducts
Structures of characterizedpyridyloxobutyl DNA adducts
Proposed activation pathways for NNN, NNK and NNKOAc
Postulated metabolic pathway medi-ating the toxicity of NNK
Other chemi-cal in smoke
Concentrations of total urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) (pg/mg creatinine) and ciga-
rettesper day in 1054 National Health and Nutrition Examination
Survey2007–2008 smokers
Adjusted geometric means in regression model with 95%
confidence intervals.
The metabolic activation and inactivation of NNK
* 11β-HSD: 11β-hydroxysteroid dehydrogenase
Steroid hormonesDrug: diureticsDrug: block 11β-HSDDrugDrug: flavonoidFlavanone
Similar structure: hormones
Relationships between Cigarette Con-sumption and Biomarkers of Tobacco
Toxin ExposureCO
NNAL Cotinine
1-HOP (PAHs metabolite)
Structures of NNK, NNAL, and NNAL-Gluc
Quantitation of Metabolites of NNK af-ter Cessation of Smokeless Tobacco Use
Time post-cessation (days)
Smokeless tobacco Smoking
NNAL t1/2: 10-18 days > cotinine t1/2 : 1days
Metabolizer phenotypes for smok-ers
• PM: poor metabolizer (ratio<2)• IM: intermediate metabolizer (ratio between 2 and 5)• EM: extensive metabolizer (ratio >5)
Comparison of free, conjugated and total urinary NNAL for 60 smokers
NNAL as a Biomarker of exposure to cigarette smoke at the preg-
nancy
• Smoking patterns during pregnancy
• Second hand smoke during preg-
nancy
• Fetal exposure
Smoking patterns during preg-nancy
Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and NNAL con-
centrations
TOBACCO SMOKING OR EXPOSURE TO SECOND-HAND SMOKE ON THE LEVELS
OF NNAL IN URINE OF MOTHER AND NEWBORN
Development of LC-MS/MS for NNAL in urine
• Simple sample preparation
• Rapid analytical time
• High sensitivity
Enzyme treat• NNAL-glucuronides hydrol-ysis
• Time: 20h
Extraction• Liquid-Liquid extraction• Time: 1h
Derivatization• N-propyl derivatization• Time: 12h
Analysis LC-MS/MS• Analytical time: 30min / test
- Sample preparation
LC-MS/MS analysis of NNAL
Blank Urine
LLOQ: 20 pg/mL
LC-MS/MS analysis of NNALBefore enzyme treatment
After enzyme treatment
NNAL-glucuronides Concentration: NNAL concentration (After enzyme treatment) – NNAL (Before enzyme treatment)
• Simple sample preparation
– Each detection of NNAL and NNAL-glucuronides
• Rapid analytical time
– Optimization of analytical column
• High sensitivity
– Optimization of sample preparation
The End